[Pharmacology of prostacyclin].
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001095:Arachidonic Acids / Q000494:pharmacology; D001792:Blood Platelets / Q000378:metabolism; D001808:Blood Vessels / Q000378:metabolism; D001920:Bradykinin / Q000494:pharmacology; D002415:Cats; D002417:Cattle; D003326:Coronary Circulation / Q000187:drug effects*; D000242:Cyclic AMP / Q000097:blood; D003864:Depression, Chemical; D004285:Dogs; D011464:Epoprostenol / Q000096:biosynthesis / Q000494:pharmacology* / Q000502:physiology; D006168:Guinea Pigs; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D011450:Prostaglandin Endoperoxides, Synthetic / Q000378:metabolism; D044262:Prostaglandin H2; D011463:Prostaglandins H / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin; D013268:Stimulation, Chemical; D014665:Vasodilator Agents
D001095:Arachidonic Acids; D011450:Prostaglandin Endoperoxides, Synthetic; D011463:Prostaglandins H; D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin; D014665:Vasodilator Agents; D000804:Angiotensin II; D044262:Prostaglandin H2; D011464:Epoprostenol; D000242:Cyclic AMP; D001920:Bradykinin